+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Contract Research Organization (CRO) Market 2024-2028

  • PDF Icon

    Report

  • 174 Pages
  • November 2023
  • Region: Global
  • TechNavio
  • ID: 5578818
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The contract research organization (CRO) market is forecasted to grow by USD 63.35 billion during 2023-2028, accelerating at a CAGR of 12.61% during the forecast period. The report on the contract research organization (CRO) market provides a holistic analysis, market size, and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growth of the biopharmaceutical industry, the increasing prevalence of chronic diseases, and the increase in M and A activities by vendors.

The contract research organization (CRO) market is segmented as below:

By Application

  • Clinical research
  • Early phase development
  • Laboratory
  • Regulatory consulting

By End-user

  • Pharmaceutical and biopharmaceutical companies
  • Medical device companies
  • Academic institutes

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the increasing number of clinical trials as one of the prime reasons driving the contract research organization (CRO) market growth during the next few years. Also, a rise in vaccine production and growing outsourcing and cost savings through the use of CRO services will lead to sizable demand in the market.

The report on the contract research organization (CRO) market covers the following areas:

  • Contract research organization (CRO) market sizing
  • Contract research organization (CRO) market forecast
  • Contract research organization (CRO) market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading contract research organization (CRO) market vendors that including BioAgile Therapeutics Pvt. Ltd, Charles River Laboratories International Inc., Clinical Trial Service B.V., CTI Clinical Trial and Consulting Inc., Ergomed Plc, Eurofins Scientific SE, Geneticist Inc., Hangzhou Tigermed Consulting Co. Ltd., ICON plc, IQVIA Holdings Inc., Konecranes, Laboratory Corp. of America Holdings, Linical Co. Ltd., Medpace Holdings Inc., Novotech Health Holdings, Parexel International Corp., Pharmaron Beijing Co. Ltd., Syneos Health Inc., Thermo Fisher Scientific Inc., and WuXi AppTec Co. Ltd. Also, the contract research organization (CRO) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global contract research organization (CRO) market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global contract research organization (cro) market 2018 - 2022 ($ billion)
4.2 Application Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
4.3 End-user Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Application
6.1 Market segments
Exhibit 30: Chart on Application - Market share 2023-2028 (%)
Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
6.2 Comparison by Application
Exhibit 32: Chart on Comparison by Application
Exhibit 33: Data Table on Comparison by Application
6.3 Clinical research - Market size and forecast 2023-2028
Exhibit 34: Chart on Clinical research - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Clinical research - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Clinical research - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Clinical research - Year-over-year growth 2023-2028 (%)
6.4 Early phase development - Market size and forecast 2023-2028
Exhibit 38: Chart on Early phase development - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Early phase development - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Early phase development - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Early phase development - Year-over-year growth 2023-2028 (%)
6.5 Laboratory - Market size and forecast 2023-2028
Exhibit 42: Chart on Laboratory - Market size and forecast 2023-2028 ($ billion)
Exhibit 43: Data Table on Laboratory - Market size and forecast 2023-2028 ($ billion)
Exhibit 44: Chart on Laboratory - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Laboratory - Year-over-year growth 2023-2028 (%)
6.6 Regulatory consulting - Market size and forecast 2023-2028
Exhibit 46: Chart on Regulatory consulting - Market size and forecast 2023-2028 ($ billion)
Exhibit 47: Data Table on Regulatory consulting - Market size and forecast 2023-2028 ($ billion)
Exhibit 48: Chart on Regulatory consulting - Year-over-year growth 2023-2028 (%)
Exhibit 49: Data Table on Regulatory consulting - Year-over-year growth 2023-2028 (%)
6.7 Market opportunity by Application
Exhibit 50: Market opportunity by Application ($ billion)
Exhibit 51: Data Table on Market opportunity by Application ($ billion)
7 Market Segmentation by End-user
7.1 Market segments
Exhibit 52: Chart on End-user - Market share 2023-2028 (%)
Exhibit 53: Data Table on End-user - Market share 2023-2028 (%)
7.2 Comparison by End-user
Exhibit 54: Chart on Comparison by End-user
Exhibit 55: Data Table on Comparison by End-user
7.3 Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028
Exhibit 56: Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
Exhibit 57: Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
Exhibit 58: Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
7.4 Medical device companies - Market size and forecast 2023-2028
Exhibit 60: Chart on Medical device companies - Market size and forecast 2023-2028 ($ billion)
Exhibit 61: Data Table on Medical device companies - Market size and forecast 2023-2028 ($ billion)
Exhibit 62: Chart on Medical device companies - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Medical device companies - Year-over-year growth 2023-2028 (%)
7.5 Academic institutes - Market size and forecast 2023-2028
Exhibit 64: Chart on Academic institutes - Market size and forecast 2023-2028 ($ billion)
Exhibit 65: Data Table on Academic institutes - Market size and forecast 2023-2028 ($ billion)
Exhibit 66: Chart on Academic institutes - Year-over-year growth 2023-2028 (%)
Exhibit 67: Data Table on Academic institutes - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by End-user
Exhibit 68: Market opportunity by End-user ($ billion)
Exhibit 69: Data Table on Market opportunity by End-user ($ billion)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 71: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 73: Chart on Geographic comparison
Exhibit 74: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 China - Market size and forecast 2023-2028
Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Exhibit 99: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
Exhibit 103: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 104: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 105: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 UK - Market size and forecast 2023-2028
Exhibit 107: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 108: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 109: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 110: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 111: Market opportunity By Geographical Landscape ($ billion)
Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 113: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 115: Overview on factors of disruption
11.4 Industry risks
Exhibit 116: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 117: Vendors covered
12.2 Market positioning of vendors
Exhibit 118: Matrix on vendor position and classification
12.3 BioAgile Therapeutics Pvt. Ltd
Exhibit 119: BioAgile Therapeutics Pvt. Ltd - Overview
Exhibit 120: BioAgile Therapeutics Pvt. Ltd - Product / Service
Exhibit 121: BioAgile Therapeutics Pvt. Ltd - Key offerings
12.4 Charles River Laboratories International Inc.
Exhibit 122: Charles River Laboratories International Inc. - Overview
Exhibit 123: Charles River Laboratories International Inc. - Business segments
Exhibit 124: Charles River Laboratories International Inc. - Key news
Exhibit 125: Charles River Laboratories International Inc. - Key offerings
Exhibit 126: Charles River Laboratories International Inc. - Segment focus
12.5 CTI Clinical Trial and Consulting Inc.
Exhibit 127: CTI Clinical Trial and Consulting Inc. - Overview
Exhibit 128: CTI Clinical Trial and Consulting Inc. - Product / Service
Exhibit 129: CTI Clinical Trial and Consulting Inc. - Key offerings
12.6 Ergomed Plc
Exhibit 130: Ergomed Plc - Overview
Exhibit 131: Ergomed Plc - Business segments
Exhibit 132: Ergomed Plc - Key news
Exhibit 133: Ergomed Plc - Key offerings
Exhibit 134: Ergomed Plc - Segment focus
12.7 Eurofins Scientific SE
Exhibit 135: Eurofins Scientific SE - Overview
Exhibit 136: Eurofins Scientific SE - Business segments
Exhibit 137: Eurofins Scientific SE - Key news
Exhibit 138: Eurofins Scientific SE - Key offerings
Exhibit 139: Eurofins Scientific SE - Segment focus
12.8 ICON plc
Exhibit 140: ICON plc - Overview
Exhibit 141: ICON plc - Product / Service
Exhibit 142: ICON plc - Key offerings
12.9 IQVIA Holdings Inc.
Exhibit 143: IQVIA Holdings Inc. - Overview
Exhibit 144: IQVIA Holdings Inc. - Business segments
Exhibit 145: IQVIA Holdings Inc. - Key news
Exhibit 146: IQVIA Holdings Inc. - Key offerings
Exhibit 147: IQVIA Holdings Inc. - Segment focus
12.10 Konecranes
Exhibit 148: Konecranes - Overview
Exhibit 149: Konecranes - Business segments
Exhibit 150: Konecranes - Key offerings
Exhibit 151: Konecranes - Segment focus
12.11 Laboratory Corp. of America Holdings
Exhibit 152: Laboratory Corp. of America Holdings - Overview
Exhibit 153: Laboratory Corp. of America Holdings - Business segments
Exhibit 154: Laboratory Corp. of America Holdings - Key news
Exhibit 155: Laboratory Corp. of America Holdings - Key offerings
Exhibit 156: Laboratory Corp. of America Holdings - Segment focus
12.12 Medpace Holdings Inc.
Exhibit 157: Medpace Holdings Inc. - Overview
Exhibit 158: Medpace Holdings Inc. - Product / Service
Exhibit 159: Medpace Holdings Inc. - Key offerings
12.13 Novotech Health Holdings
Exhibit 160: Novotech Health Holdings - Overview
Exhibit 161: Novotech Health Holdings - Product / Service
Exhibit 162: Novotech Health Holdings - Key offerings
12.14 Parexel International Corp.
Exhibit 163: Parexel International Corp. - Overview
Exhibit 164: Parexel International Corp. - Product / Service
Exhibit 165: Parexel International Corp. - Key news
Exhibit 166: Parexel International Corp. - Key offerings
12.15 Syneos Health Inc.
Exhibit 167: Syneos Health Inc. - Overview
Exhibit 168: Syneos Health Inc. - Business segments
Exhibit 169: Syneos Health Inc. - Key offerings
Exhibit 170: Syneos Health Inc. - Segment focus
12.16 Thermo Fisher Scientific Inc.
Exhibit 171: Thermo Fisher Scientific Inc. - Overview
Exhibit 172: Thermo Fisher Scientific Inc. - Business segments
Exhibit 173: Thermo Fisher Scientific Inc. - Key news
Exhibit 174: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 175: Thermo Fisher Scientific Inc. - Segment focus
12.17 WuXi AppTec Co. Ltd.
Exhibit 176: WuXi AppTec Co. Ltd. - Overview
Exhibit 177: WuXi AppTec Co. Ltd. - Business segments
Exhibit 178: WuXi AppTec Co. Ltd. - Key offerings
Exhibit 179: WuXi AppTec Co. Ltd. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 180: Inclusions checklist
Exhibit 181: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 182: Currency conversion rates for US$
13.4 Research methodology
Exhibit 183: Research methodology
Exhibit 184: Validation techniques employed for market sizing
Exhibit 185: Information sources
13.5 List of abbreviations
Exhibit 186: List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 5: Executive Summary - Chart on Market Segmentation by Application
Exhibit 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 7: Executive Summary - Chart on Incremental Growth
Exhibit 8: Executive Summary - Data Table on Incremental Growth
Exhibit 9: Executive Summary - Chart on Vendor Market Positioning
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
Exhibit 12: Offerings of vendors included in the market definition
Exhibit 13: Market segments
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 18: Historic Market Size - Data Table on global contract research organization (cro) market 2018 - 2022 ($ billion)
Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
Exhibit 30: Chart on Application - Market share 2023-2028 (%)
Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
Exhibit 32: Chart on Comparison by Application
Exhibit 33: Data Table on Comparison by Application
Exhibit 34: Chart on Clinical research - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Clinical research - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Clinical research - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Clinical research - Year-over-year growth 2023-2028 (%)
Exhibit 38: Chart on Early phase development - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Early phase development - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Early phase development - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Early phase development - Year-over-year growth 2023-2028 (%)
Exhibit 42: Chart on Laboratory - Market size and forecast 2023-2028 ($ billion)
Exhibit 43: Data Table on Laboratory - Market size and forecast 2023-2028 ($ billion)
Exhibit 44: Chart on Laboratory - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Laboratory - Year-over-year growth 2023-2028 (%)
Exhibit 46: Chart on Regulatory consulting - Market size and forecast 2023-2028 ($ billion)
Exhibit 47: Data Table on Regulatory consulting - Market size and forecast 2023-2028 ($ billion)
Exhibit 48: Chart on Regulatory consulting - Year-over-year growth 2023-2028 (%)
Exhibit 49: Data Table on Regulatory consulting - Year-over-year growth 2023-2028 (%)
Exhibit 50: Market opportunity by Application ($ billion)
Exhibit 51: Data Table on Market opportunity by Application ($ billion)
Exhibit 52: Chart on End-user - Market share 2023-2028 (%)
Exhibit 53: Data Table on End-user - Market share 2023-2028 (%)
Exhibit 54: Chart on Comparison by End-user
Exhibit 55: Data Table on Comparison by End-user
Exhibit 56: Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
Exhibit 57: Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
Exhibit 58: Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibit 60: Chart on Medical device companies - Market size and forecast 2023-2028 ($ billion)
Exhibit 61: Data Table on Medical device companies - Market size and forecast 2023-2028 ($ billion)
Exhibit 62: Chart on Medical device companies - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Medical device companies - Year-over-year growth 2023-2028 (%)
Exhibit 64: Chart on Academic institutes - Market size and forecast 2023-2028 ($ billion)
Exhibit 65: Data Table on Academic institutes - Market size and forecast 2023-2028 ($ billion)
Exhibit 66: Chart on Academic institutes - Year-over-year growth 2023-2028 (%)
Exhibit 67: Data Table on Academic institutes - Year-over-year growth 2023-2028 (%)
Exhibit 68: Market opportunity by End-user ($ billion)
Exhibit 69: Data Table on Market opportunity by End-user ($ billion)
Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 71: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 73: Chart on Geographic comparison
Exhibit 74: Data Table on Geographic comparison
Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibit 99: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 103: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 104: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 105: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 107: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 108: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 109: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 110: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibit 111: Market opportunity By Geographical Landscape ($ billion)
Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibit 113: Impact of drivers and challenges in 2023 and 2028
Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
Exhibit 115: Overview on factors of disruption
Exhibit 116: Impact of key risks on business
Exhibit 117: Vendors covered
Exhibit 118: Matrix on vendor position and classification
Exhibit 119: BioAgile Therapeutics Pvt. Ltd - Overview
Exhibit 120: BioAgile Therapeutics Pvt. Ltd - Product / Service
Exhibit 121: BioAgile Therapeutics Pvt. Ltd - Key offerings
Exhibit 122: Charles River Laboratories International Inc. - Overview
Exhibit 123: Charles River Laboratories International Inc. - Business segments
Exhibit 124: Charles River Laboratories International Inc. - Key news
Exhibit 125: Charles River Laboratories International Inc. - Key offerings
Exhibit 126: Charles River Laboratories International Inc. - Segment focus
Exhibit 127: CTI Clinical Trial and Consulting Inc. - Overview
Exhibit 128: CTI Clinical Trial and Consulting Inc. - Product / Service
Exhibit 129: CTI Clinical Trial and Consulting Inc. - Key offerings
Exhibit 130: Ergomed Plc - Overview
Exhibit 131: Ergomed Plc - Business segments
Exhibit 132: Ergomed Plc - Key news
Exhibit 133: Ergomed Plc - Key offerings
Exhibit 134: Ergomed Plc - Segment focus
Exhibit 135: Eurofins Scientific SE - Overview
Exhibit 136: Eurofins Scientific SE - Business segments
Exhibit 137: Eurofins Scientific SE - Key news
Exhibit 138: Eurofins Scientific SE - Key offerings
Exhibit 139: Eurofins Scientific SE - Segment focus
Exhibit 140: ICON plc - Overview
Exhibit 141: ICON plc - Product / Service
Exhibit 142: ICON plc - Key offerings
Exhibit 143: IQVIA Holdings Inc. - Overview
Exhibit 144: IQVIA Holdings Inc. - Business segments
Exhibit 145: IQVIA Holdings Inc. - Key news
Exhibit 146: IQVIA Holdings Inc. - Key offerings
Exhibit 147: IQVIA Holdings Inc. - Segment focus
Exhibit 148: Konecranes - Overview
Exhibit 149: Konecranes - Business segments
Exhibit 150: Konecranes - Key offerings
Exhibit 151: Konecranes - Segment focus
Exhibit 152: Laboratory Corp. of America Holdings - Overview
Exhibit 153: Laboratory Corp. of America Holdings - Business segments
Exhibit 154: Laboratory Corp. of America Holdings - Key news
Exhibit 155: Laboratory Corp. of America Holdings - Key offerings
Exhibit 156: Laboratory Corp. of America Holdings - Segment focus
Exhibit 157: Medpace Holdings Inc. - Overview
Exhibit 158: Medpace Holdings Inc. - Product / Service
Exhibit 159: Medpace Holdings Inc. - Key offerings
Exhibit 160: Novotech Health Holdings - Overview
Exhibit 161: Novotech Health Holdings - Product / Service
Exhibit 162: Novotech Health Holdings - Key offerings
Exhibit 163: Parexel International Corp. - Overview
Exhibit 164: Parexel International Corp. - Product / Service
Exhibit 165: Parexel International Corp. - Key news
Exhibit 166: Parexel International Corp. - Key offerings
Exhibit 167: Syneos Health Inc. - Overview
Exhibit 168: Syneos Health Inc. - Business segments
Exhibit 169: Syneos Health Inc. - Key offerings
Exhibit 170: Syneos Health Inc. - Segment focus
Exhibit 171: Thermo Fisher Scientific Inc. - Overview
Exhibit 172: Thermo Fisher Scientific Inc. - Business segments
Exhibit 173: Thermo Fisher Scientific Inc. - Key news
Exhibit 174: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 175: Thermo Fisher Scientific Inc. - Segment focus
Exhibit 176: WuXi AppTec Co. Ltd. - Overview
Exhibit 177: WuXi AppTec Co. Ltd. - Business segments
Exhibit 178: WuXi AppTec Co. Ltd. - Key offerings
Exhibit 179: WuXi AppTec Co. Ltd. - Segment focus
Exhibit 180: Inclusions checklist
Exhibit 181: Exclusions checklist
Exhibit 182: Currency conversion rates for US$
Exhibit 183: Research methodology
Exhibit 184: Validation techniques employed for market sizing
Exhibit 185: Information sources
Exhibit 186: List of abbreviations

Executive Summary

The analyst recognizes the following companies as the key players in the global contract research organization (CRO) market: BioAgile Therapeutics Pvt. Ltd, Charles River Laboratories International Inc., Clinical Trial Service B.V., CTI Clinical Trial and Consulting Inc., Ergomed Plc, Eurofins Scientific SE, Geneticist Inc., Hangzhou Tigermed Consulting Co. Ltd., ICON plc, IQVIA Holdings Inc., Konecranes, Laboratory Corp. of America Holdings, Linical Co. Ltd., Medpace Holdings Inc., Novotech Health Holdings, Parexel International Corp., Pharmaron Beijing Co. Ltd., Syneos Health Inc., Thermo Fisher Scientific Inc., and WuXi AppTec Co. Ltd.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is increasing the number of clinical trials.'

According to the report, one of the major drivers for this market is the growth of the biopharmaceutical industry.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • BioAgile Therapeutics Pvt. Ltd
  • Charles River Laboratories International Inc.
  • Clinical Trial Service B.V.
  • CTI Clinical Trial and Consulting Inc.
  • Ergomed Plc
  • Eurofins Scientific SE
  • Geneticist Inc.
  • Hangzhou Tigermed Consulting Co. Ltd.
  • ICON plc
  • IQVIA Holdings Inc.
  • Konecranes
  • Laboratory Corp. of America Holdings
  • Linical Co. Ltd.
  • Medpace Holdings Inc.
  • Novotech Health Holdings
  • Parexel International Corp.
  • Pharmaron Beijing Co. Ltd.
  • Syneos Health Inc.
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec Co. Ltd.

Related Topics

Related Reports

Global Life Science Software Market 2024-2028 - Product Image

Global Life Science Software Market 2024-2028

  • Report
  • 173 Pages
  • Global
From
Global High Throughput Screening (HTS) Market 2024-2028 - Product Image

Global High Throughput Screening (HTS) Market 2024-2028

  • Report
  • 171 Pages
  • Global
From
Metabolomics Market - Global Outlook & Forecast 2023-2028 - Product Image

Metabolomics Market - Global Outlook & Forecast 2023-2028

  • Report
  • 305 Pages
  • Global
From
Global Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Forecast 2024-2030 - Product Image

Global Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Forecast 2024-2030

  • Report
  • 194 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.